Literature DB >> 8666336

Contribution of immune response to the hepatic fibrosis induced by porcine serum.

E Bhunchet1, Y Eishi, K Wake.   

Abstract

To investigate whether hepatic fibrosis induced by porcine serum in rats is caused by an immune reaction to porcine serum, rats that were immunologically tolerant exclusively to porcine serum were subjected to the repeated injection of porcine serum over a long period. This porcine serum-tolerant group consisted of 15 Wistar rats that had been injected intraperitoneally with porcine serum twice a week from the first postnatal day for 18 weeks. The control group consisted of 16 Wistar rats, aged 8 weeks, that were injected intraperitoneally with porcine serum twice a week for 10 weeks. Livers were fixed and examined by light microscopy. The serum of each rat was subjected to indirect enzyme-linked immunosorbent assay (ELISA) to measure the level of antibody to porcine albumin. In addition, immunohistochemical staining for ED1 was performed on untreated normal and porcine serum-induced fibrotic rat livers to examine the distribution of macrophages and their precursors, the monocytes. All rats in the tolerant group showed an extremely low antibody level (x = 68.27 +/- 4.53), and none (0/15) developed hepatic fibrosis. The majority of rats in the control group showed a very high antibody level (x = 1242.19 +/- 201.15); 75 percent (12/16) developed hepatic fibrosis. Data indicate that, despite the prolonged, repeated injections of porcine serum, if an immune response to porcine serum does not occur, the rats do not develop hepatic fibrosis. The porcine serum-tolerant rats developed hepatic fibrosis after 4 weeks of CCl4 treatment, indicating that injection of porcine serum into neonatal rats did not cause anergy of fibrogenesis, thereby preventing the animal from developing hepatic fibrosis. In normal rat liver, ED1-positive cells, which include nearly all Kupffer cells, were located pre-dominantly in the periportal area. In fibrotic rat liver, ED1-positive cells aggregated prominently in the newly formed and advanced connective tissue septa developed mainly between the neighboring central veins, and in fibrotic parts of the liver capsule. Aggregation of ED1-positive cells was rarely observed in nonfibrotic parts of the liver capsule. The difference between normal and fibrotic rat liver in distribution of EDl-positive cells suggests an involvement of macrophages in fibrogenesis and septum formation. In conclusion, our study showed a significant contribution by the immune response to porcine serum antigens leading to porcine serum-induced rat hepatic fibrosis--processes in which macrophages may be important. This study may lead to an understanding of the mechanism responsible for this form of experimental hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666336     DOI: 10.1053/jhep.1996.v23.pm0008666336

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Hepatic stimulator substance alleviates toxin-induced and immune-mediated liver injury and fibrosis in rats.

Authors:  Xuerui Yi; Ming Song; Youcheng Yuan; Xinrui Zhang; Wenyin Chen; Jin Li; Minghua Tong; Guangze Liu; Song You; Xiangping Kong
Journal:  Dig Dis Sci       Date:  2012-04-27       Impact factor: 3.199

2.  Bone marrow progenitor cells do not contribute to liver fibrogenic cells.

Authors:  Bruno Diaz Paredes; Lanuza Alaby Pinheiro Faccioli; Luiz Fernando Quintanilha; Karina Dutra Asensi; Camila Zaverucha do Valle; Paulo César Canary; Christina Maeda Takiya; Antonio Carlos Campos de Carvalho; Regina Coeli Dos Santos Goldenberg
Journal:  World J Hepatol       Date:  2012-10-27

3.  Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride.

Authors:  J Shi; K Aisaki; Y Ikawa; K Wake
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

4.  Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats.

Authors:  Kosuke Kaji; Hitoshi Yoshiji; Yasuhide Ikenaka; Ryuichi Noguchi; Yosuke Aihara; Akitoshi Douhara; Kei Moriya; Hideto Kawaratani; Yusaku Shirai; Junichi Yoshii; Koji Yanase; Mitsuteru Kitade; Tadashi Namisaki; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2013-03-12       Impact factor: 7.527

5.  Typing of hepatic nonparenchymal cells using fibulin-2 and cytoglobin/STAP as liver fibrogenesis-related markers.

Authors:  Yuko Tateaki; Tomohiro Ogawa; Norifumi Kawada; Toshihiko Kohashi; Koji Arihiro; Chise Tateno; Masanobu Obara; Katsutoshi Yoshizato
Journal:  Histochem Cell Biol       Date:  2004-06-22       Impact factor: 4.304

6.  Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats.

Authors:  Norihisa Nishimura; Mitsuteru Kitade; Ryuichi Noguchi; Tadashi Namisaki; Kei Moriya; Kosuke Takeda; Yasushi Okura; Yosuke Aihara; Akitoshi Douhara; Hideto Kawaratani; Kiyoshi Asada; Hitoshi Yoshiji
Journal:  J Gastroenterol       Date:  2016-03-29       Impact factor: 7.527

7.  Alterations of bone marrow sinusoidal endothelium in rat and patients with liver cirrhosis.

Authors:  Song Zhao; Ying-Mei Fu; Xiu-Fen Li; Zhan-Feng Jin; Rui-Bo Zhao; Qi Huang; Feng-Min Zhang; Wei-Hui Zhang
Journal:  Dig Dis Sci       Date:  2009-04-01       Impact factor: 3.199

8.  Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosis.

Authors:  Tadashi Namisaki; Kei Moriya; Mitsuteru Kitade; Kosuke Takeda; Kosuke Kaji; Yasushi Okura; Naotaka Shimozato; Shinya Sato; Norihisa Nishimura; Kenichiro Seki; Hideto Kawaratani; Hiroaki Takaya; Yasuhiko Sawada; Takemi Akahane; Soichiro Saikawa; Keisuke Nakanishi; Takuya Kubo; Masanori Furukawa; Ryuichi Noguchi; Kiyoshi Asada; Koh Kitagawa; Takahiro Ozutsumi; Yuki Tsuji; Daisuke Kaya; Yukihisa Fujinaga; Hitoshi Yoshiji
Journal:  Hepatol Commun       Date:  2017-09-19

9.  TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats.

Authors:  Daisuke Kaya; Kosuke Kaji; Yuki Tsuji; Satoko Yamashita; Koh Kitagawa; Takahiro Ozutsumi; Yukihisa Fujinaga; Hiroaki Takaya; Hideto Kawaratani; Kei Moriya; Tadashi Namisaki; Takemi Akahane; Hitoshi Yoshiji
Journal:  Cells       Date:  2019-09-26       Impact factor: 6.600

10.  Macrophages, myofibroblasts and mast cells in a rat liver infected with Capillaria hepatica.

Authors:  Won-Il Jeong; Sun-Hee Do; Il-Hwa Hong; Ae-Ri Ji; Jin-Kyu Park; Mi-Ran Ki; Seung-Chun Park; Kyu-Shik Jeong
Journal:  J Vet Sci       Date:  2008-06       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.